Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > World News related to Covid/Variants !

<< Previous

Bullboard Posts

Next >>

Comment by TheTerminator1on Jul 08, 2021 7:44am

112 Views

Post# 33510818

RE:RE:RE:World News related to Covid/Variants !

The US and the rest of te world will feel the pain for many years to come...According to the World Leaders,Covid-19 and its variants are here to stay and we will have to find a way to live with it...Vaccines can only do so much..

Oral Meds like Bucillamine will soon make it's entry on the world scene...